Wells Fargo
ACET icon

Wells Fargo’s Adicet Bio ACET Stock Holding History

Wells Fargo’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,181
Closed -$44.4K – 6865
2024
Q1 		$44.4K Buy
1,181
+595
+102% +$24.6K ﹤0.01% 5304
2023
Q4 		$17.7K Buy
586
+115
+24% +$2.51K ﹤0.01% 5677
2023
Q3 		$10.3K Sell
471
-253
-35% -$8.94K ﹤0.01% 5803
2023
Q2 		$28.1K Buy
724
+387
+115% +$34.2K ﹤0.01% 5632
2023
Q1 		$31.1K Buy
+337
New +$42.3K ﹤0.01% 5430
2022
Q4 		– Sell
-58
Closed -$13K – 7427
2022
Q3 		$13K Buy
58
+40
+222% +$10.2K ﹤0.01% 5562
2022
Q2 		$4K Sell
18
-84
-82% -$18.4K ﹤0.01% 6058
2022
Q1 		$33K Sell
102
-441
-81% -$101K ﹤0.01% 5823
2021
Q4 		$152K Sell
543
-257
-32% -$44.1K ﹤0.01% 5419
2021
Q3 		$100K Buy
+800
New +$99.2K ﹤0.01% 5384
2021
Q2 		– Hold
0
– – – 6843
2021
Q1 		– Sell
-581
Closed -$133K – 6843
2020
Q4 		$130K Buy
+581
New +$119K ﹤0.01% 5257
2020
Q3 		– Hold
0
– – – 6280
2020
Q2 		– Sell
-329
Closed -$38K – 6234
2020
Q1 		$38K Buy
329
+259
+370% +$38.4K ﹤0.01% 5428
2019
Q4 		$12K Sell
70
-25
-26% -$12.7K ﹤0.01% 5850
2019
Q3 		$94K Buy
95
+71
+296% +$79.3K ﹤0.01% 5345
2019
Q2 		$27K Sell
24
-7
-23% -$6.34K ﹤0.01% 5723
2019
Q1 		$23K Hold
31
– – ﹤0.01% 5497
2018
Q4 		$30K Buy
31
+20
+182% +$26.3K ﹤0.01% 5670
2018
Q3 		$19K Buy
11
+4
+57% +$5.22K ﹤0.01% 5833
2018
Q2 		$7K Sell
7
-2
-22% -$2.15K ﹤0.01% 6021
2018
Q1 		$10K Buy
+9
New +$16.5K ﹤0.01% 5940

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Wells Fargo's ACET Position: Q2 2024 in Review

Wells Fargo sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 1,181 shares — an estimated $44.4K sold.

Wells Fargo first reported a position in ACET in Q1 2018 and held it in 20 quarters. The position peaked at $152K in Q4 2021. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Wells Fargo reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 1,181 Adicet Bio shares in Q2 2024, an estimated $44.4K.
  • Wells Fargo first reported a position in Adicet Bio in Q1 2018 and held it in 20 quarters.
  • Wells Fargo's Adicet Bio position peaked at $152K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.